Omgeneum
OMGENEUM is a bioengineering technology company developing regenerative "precision curative modalities" to treat severe neurodegenerative diseases like Alzheimer's and Parkinson's, as well as conditions resulting from traumatic events such as stroke and brain injury. Their platform, ARMADYNE Insights, is an AI-powered digital therapeutics ecosystem designed to optimize regenerative stem cell treatments and accelerate the delivery of next-generation therapies. The company aims to harness the body's own regenerative capabilities through a combination of AI-algorithmic modulation of neuro, bio, and cellular pathways and iRis devices to achieve endogenous tissue regeneration. Their vision is to non-invasively transform the treatment of brain disorders by activating the body's self-healing mechanisms, offering a new age of precision healing with the potential to cure devastating neurological diseases.
Omgeneum
OMGENEUM is a bioengineering technology company developing regenerative "precision curative modalities" to treat severe neurodegenerative diseases like Alzheimer's and Parkinson's, as well as conditions resulting from traumatic events such as stroke and brain injury. Their platform, ARMADYNE Insights, is an AI-powered digital therapeutics ecosystem designed to optimize regenerative stem cell treatments and accelerate the delivery of next-generation therapies. The company aims to harness the body's own regenerative capabilities through a combination of AI-algorithmic modulation of neuro, bio, and cellular pathways and iRis devices to achieve endogenous tissue regeneration. Their vision is to non-invasively transform the treatment of brain disorders by activating the body's self-healing mechanisms, offering a new age of precision healing with the potential to cure devastating neurological diseases.